Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Human Kallikrein 1 Antikörper:
anti-Mouse (Murine) Kallikrein 1 Antikörper:
anti-Rat (Rattus) Kallikrein 1 Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Human Polyclonal Kallikrein 1 Primary Antibody für ELISA, WB - ABIN252921
Gao, Clermont, Rook, Fonda, Srinivasan, Wojtkowski, Fujimoto, Avery, Arrigg, Bursell, Aiello, Feener: Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation. in Nature medicine 2007
Show all 2 Pubmed References
Mouse (Murine) Polyclonal Kallikrein 1 Primary Antibody für ELISA, IP - ABIN4227986
Christophi, Isackson, Blaber, Blaber, Rodriguez, Scarisbrick: Distinct promoters regulate tissue-specific and differential expression of kallikrein 6 in CNS demyelinating disease. in Journal of neurochemistry 2004
Our results indicate that during severe sepsis and septic shock, a decrease in plasma concentrations of kallistatin (zeige SERPINA4 Antikörper) reflects increased severity and poorer outcome of disease.
data suggest that overexpression of kallistatin (zeige SERPINA4 Antikörper) interferes with lymphopoiesis, ultimately impacting the level of circulating CD19 (zeige CD19 Antikörper)(+) B lymphocytes.
Recognition of anti-tumor necrosis factor-alpha (TNF-alpha) or Kallikrein Inhibitor may lead to therapeutics to enhance existing treatments for patients who do not respond to anti-vascular endothelial growth factor (VEGF) therapies.
increasing the serum levels of AngII increased the risk of acute myocardial infarction (AMI (zeige CFD Antikörper)); the risk of AMI (zeige CFD Antikörper) increased when the serum levels of AngII and KLK1 simultaneously increased; individuals with the combined genotypes of ACE (zeige ACE Antikörper) DD and KLK1 GG showed increased risk of AMI (zeige CFD Antikörper) compared with those with the combined genotypes of ACE (zeige ACE Antikörper) II and KLK1 AA
The rs5516 G allele of KLK1 was significantly associated with aortic aneurysm
Kallistatin (zeige SERPINA4 Antikörper) levels were correlated with some markers of systemic inflammation in the HIV population.
KLK1 rs5516 SNP is not related to the incidence of Alzheimer's disease in a Hunan Han Chinese population.
TK promoted cell survival and beta-catenin (zeige CTNNB1 Antikörper) degradation in serum-starved SH-SY5Y cells via increasing autophagy.
Increased kallistatin (zeige SERPINA4 Antikörper) levels in type 1 diabetes and its relation with carotid intima media thickness may reflect vascular dysfunction and suggest a link between micro- and macro-angiopathy.
reveal novel mechanisms of kallistatin (zeige SERPINA4 Antikörper) in inducing apoptosis and autophagy in breast cancer cells
Polypeptides identified based on immunorecognition by autoantibodies in sera from IQI/Jic mice affected with autoimmune disease (>12 weeks of age) were tissue kallikrein (Klk)-1 and -13 and were cross-reactive to the autoantibodies.
Protective effects of Tissue kallikrein gene transfer on ischemic diseases.
TK, like several other proteases, can activate ENaC (zeige SCNN1A Antikörper) in the kidney and the colon.
Tissue kallikrein and kinins do not influence the trophicity of kidneys, the synthesis and secretion of renin (zeige REN Antikörper), blood pressure increase, and cardiac remodeling due to renin (zeige REN Antikörper) angiotensin system activation.
tissue kallikrein knockout mice had a significant two-fold increase in albuminuria
The study suggests that kallikrein plays an antihypertensive role in hyperaldosteronism.
These data do not support a role for the TK-kinin system, protective or deleterious, in the development of insulin (zeige INS Antikörper) resistance and diabetes.
Lower excretion of active renin (zeige REN Antikörper) and prorenin in TK(-/-) compared to TK(+/+) suggest coordinated regulation of the two proteins in their participation to collecting duct function.
Plasma kallikrein (zeige KLKB1 Antikörper)-deficient mice challenged with transient middle cerebral artery occlusion developed significantly smaller brain infarctions.
The data of this study presented support the conclusion that Klk6 is an important participant in the immunopathogenic events that drive TMEV-IDD (zeige DGS2 Antikörper) at acute through early chronic time points.
Inhibits human amidolytic and kininogenase activities of tissue kallikrein. Inhibition is achieved by formation of an equimolar, heat- and SDS-stable complex between the inhibitor and the enzyme, and generation of a small C-terminal fragment of the inhibitor due to cleavage at the reactive site by tissue kallikrein.
, glandular kallikrein 1
, kallikrein 1, renal/pancreas/salivary
, kallikrein serine protease 1
, kidney/pancreas/salivary gland kallikrein
, tissue kallikrein
, glandular kallikrein K1
, kallikrein 6
, kallikrein renal/pancreas/salivary
, renal kallikrein
, tissue kallikrein-6
, true tissue kallikrein
, glandular kallikrein
, PS kallikrein
, kallikrein 1-related peptidase b3
, nerve growth factor gamma chain
, nerve growth factor gamma polypeptide
, pancreatic kallikrein
, kallikrein inhibitor
, peptidase inhibitor 4
, protease inhibitor 4 (kallistatin)
, serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4
, serpin A4